Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Clinical trial NCT07225361 · RECRUITING

Trial details

NCT number: NCT07225361
Sponsor: Northwestern University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Multiple Sclerosis (MS) - Relapsing-remitting

Start date: 2025-11-28
Primary completion: 2029-03-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.